Document is current

Article History

Received: 2 February 2026

Accepted: 18 March 2026

First Online: 2 April 2026

Declarations

:

: David Saceda-Corralo is an investigator in clinical trials and/or affiliated with (Presentations/Advisory boards) for Eli Lilly and Company, L’Oreal, Pfizer Inc., ISDIN, Cantabria Labs. Vice president of the Spanish Hair Research Society (2023 to present). David Saceda-Corralo is an Editorial Board member of Dermatology and Therapy . David Saceda-Corralo was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Ralf Paus serves on the Scientific Advisory Board of Olistic, Spain, and DermaliQ, USA, and is an employee of CUTANEON, Germany. Michela Starace has no conflicts of interest. Sergio Vañó-Galván is advisor and speaker of Lilly, Pfizer, Pierre Fabre, Loreal and Cantabria Labs. Bianca Maria Piraccini is advisor of Lilly and Sun Pharma, and speaker of Lilly. Manuel Sáez has no conflicts of interest.

: The study adhered to the ethical principles outlined in the Declaration of Helsinki and was approved by the Research Ethics Committee of Hospital Universitario Ramón y Cajal (Madrid, Spain); CEIm number 82/26. No patient data was collected or analyzed.